Previous Article | Next Article ![]()
J. Virol., 05 1996, 3235-3241, Vol 70, No. 5
SA Afione, CK Conrad, WG Kearns, S Chunduru, R Adams, TC Reynolds, WB Guggino, GR Cutting, BJ Carter and TR Flotte
Gene therapy vectors based on human DNA viruses could be mobilized or
rescued from individuals who are subsequently infected with the
corresponding wild-type (wt) helper viruses. This phenomenon has been
effectively modeled in vitro with both adenovirus (Ad) and adeno-
associated virus (AAV) vectors but has not previously been studied in vivo.
In the current study, we have developed an in vivo model to study the
interactions of a recombinant AAV vector (AAV-CFTR) with wt AAV type 2
(AAV2) and a host range mutant Ad (Ad2HR405) for which monkey cells are
permissive (D.E.Brough, S.A.Rice, S.Sell, and D.F.Klessig, J. Virol.
55:206-212, 1985). AAV-CFTR was administered to the respiratory epithelium
of the nose or lung of rhesus macaques. Primary cells were harvested from
the infusion site at time points up to 3 months after vector administration
to confirm vector DNA persistence. Vector DNA was present in episomal form
and could be rescued in vitro only by addition of wt AAV2 and Ad. In in
vivo rescue studies, vector was administered before or after wt-AAV2 and
Ad2HR405 infection, and the shedding of AAV- CFTR was examined. Ad2HR405
and wt-AAV2 infections were established in the nose with concomitant
administration. wt-AAV2 replication occurred in the lung when virus was
administered directly at a high titer to the lower respiratory tract.
AAV-CFTR vector rescue was also observed in the latter setting. Although
these studies were performed with small numbers of animals within each
group, it appears that AAV-CFTR DNA persists in the primate respiratory
tract and that this model may be useful for studies of recombinant AAV
vector rescue.
Copyright © 1996, American Society for Microbiology
In vivo model of adeno-associated virus vector persistence and rescue
Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|